| Date Filed | Type | Description |
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/05/2023 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 01/05/2023 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 165 shares
@ $0
Granted 1,929 options to buy
@ $725.89, valued at
$1.4M
|
|
| 01/05/2023 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 165 shares
@ $0
Granted 1,929 options to buy
@ $725.89, valued at
$1.4M
|
|
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 16 shares
@ $686.89, valued at
$11k
Sold 321 shares
@ $687.9, valued at
$220.8k
Sold 637 shares
@ $688.71, valued at
$438.7k
Sold 1,009 shares
@ $689.56, valued at
$695.8k
Sold 692 shares
@ $690.65, valued at
$477.9k
Sold 554 shares
@ $691.59, valued at
$383.1k
Sold 85 shares
@ $696.13, valued at
$59.2k
Sold 160 shares
@ $697.29, valued at
$111.6k
Sold 208 shares
@ $698.44, valued at
$145.3k
Sold 80 shares
@ $699.82, valued at
$56k
Sold 16 shares
@ $702.36, valued at
$11.2k
|
|
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2022 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 19,900 shares
@ $31.61, valued at
$629k
Sold 100 shares
@ $32.43, valued at
$3.2k
|
|
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2022 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 8,402 shares
@ $33.4, valued at
$280.6k
Sold 11,598 shares
@ $34.14, valued at
$396k
|
|
| 03/23/2022 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 7,439 shares
@ $690, valued at
$5.1M
Exercised 7,439 options to buy
@ $380.95, valued at
$2.8M
|
|
| 03/18/2022 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 4,361 shares
@ $675, valued at
$2.9M
Sold 7,830 shares
@ $680, valued at
$5.3M
Exercised 4,361 options to buy
@ $374.12, valued at
$1.6M
Exercised 7,830 options to buy
@ $376.69, valued at
$2.9M
|
|
| 02/17/2022 |
5
| Tessier-Lavigne Marc (Director) has filed a Form 5 on Denali Therapeutics Inc. |
| 01/05/2022 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 191 shares
@ $0
Granted 2,707 options to buy
@ $625.6, valued at
$1.7M
|
|
| 12/30/2021 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Gifted 300,000 shares
@ $0
Gifted 100,000 shares
@ $0
Sold 3,732 shares
@ $44.37, valued at
$165.6k
Sold 10,700 shares
@ $43.88, valued at
$469.5k
Sold 3,343 shares
@ $45.13, valued at
$150.9k
Sold 3,377 shares
@ $45.59, valued at
$154k
Gifted 100,000 shares
@ $0
Sold 3,602 shares
@ $44.38, valued at
$159.9k
Sold 10,700 shares
@ $43.87, valued at
$469.4k
Sold 5,625 shares
@ $45.31, valued at
$254.9k
Sold 900 shares
@ $45.71, valued at
$41.1k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 14,223 shares
@ $55.606, valued at
$790.9k
Sold 29,593 shares
@ $56.906, valued at
$1.7M
Sold 6,184 shares
@ $57.595, valued at
$356.2k
|
|
| 03/03/2021 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 18,770 shares
@ $64.361, valued at
$1.2M
Sold 37,445 shares
@ $65.634, valued at
$2.5M
Sold 18,316 shares
@ $66.554, valued at
$1.2M
Sold 14,945 shares
@ $67.57, valued at
$1M
Sold 6,011 shares
@ $68.504, valued at
$411.8k
Sold 3,482 shares
@ $69.589, valued at
$242.3k
Sold 1,031 shares
@ $71.351, valued at
$73.6k
|
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 400,000 shares
@ $26.1, valued at
$10.4M
|
|
| 06/05/2020 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 15,183 options to buy
@ $28.82, valued at
$437.6k
Granted 3,253 restricted stock units
@ $0 |
|
| 05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 320 shares
@ $0
Granted 4,361 options to buy
@ $374.12, valued at
$1.6M
|
|
| 05/31/2019 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 27,245 options to buy
@ $19.5, valued at
$531.3k
|
|
|